Select Page

UK approves Pfizer/BioNTech Covid shot for 12- to 15-year-olds – ET HealthWorld


London: Britain’s medicines regulator stated on Friday it had accredited the Covid-19 vaccine developed by Pfizer and BioNTech to be used on 12- to 15-year-olds, following related clearances within the U.S. and the E.U.

The regulator stated it will now be as much as the nation’s Joint Committee on Vaccination and Immunisation (JCVI) to determine whether or not to go forward and inoculate this age group as a part of Britain’s vaccination roll-out plan.

Youngsters aged 12-15 are already receiving the Pfizer shot in the USA, whereas France and Germany are planning to start out providing it to that age group this month.

Britain’s Well being and Social Care division stated it will present an replace as soon as the JCVI had made its choice.

The chief govt of the UK Medicines and Healthcare merchandise Regulatory Company June Raine stated in an announcement that her company had rigorously reviewed the medical trial information in kids aged 12 to fifteen years outdated.

“(We) have concluded that the Pfizer/BioNTech Covid-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk,” she stated.

Nonetheless, giving vaccines to youthful individuals in prosperous international locations whereas many components of the world await doses for older and extra weak individuals has raised considerations. The World Well being Organisation has urged wealthy international locations to present pictures to the COVAX scheme as an alternative.



Source link

Leave a Reply

Weather

New Delhi
38°
Haze
05:2419:22 IST
Feels like: 41°C
Wind: 10km/h E
Humidity: 33%
Pressure: 997.97mbar
UV index: 0
ThuFriSatSunMon
40/29°C
40/29°C
39/29°C
39/30°C
40/31°C

Stock Update

  • Loading stock data...

Covid-19

Live COVID-19 statistics for
World
Confirmed
177,682,872
Recovered
115,937,280
Deaths
3,851,268
Last updated: 3 minutes ago

Subscribe Newsproplus.com

Enter your email address to receive notifications of new update by email.